drugset / Trial / NCT00820664

A Clinical Study to Evaluate the Effects of Estrogen in Healthy Postmenopausal Women

NCT00820664

Phase 1 Completed 29 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindDiagnostic

Summary

The purpose of this study is to examine the effect of two different dose levels of estrogen or placebo in healthy postmenopausal women by measuring the changes in hormone levels and examining the changes in the uterine lining (endometrium).

Timeline

Start
2008-12
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Estradiol Other / unclassified 0.5 mg
Comparator Estradiol Other / unclassified 2 mg

Indications

No indication recorded.